• Erin Seery, MD, 2015 PsychSign Presenter

    Psychiatry Fellow Dr. Erin Seery talks about one of the unique benefits the Austen Riggs Center offers its Fellows: support for two years of personal analysis.

  • Heather Forouhar Graff, MD, is a psychiatry Fellow in psychoanalytic studies at the Austen Riggs Center.

    Psychiatry Fellow Dr. Heather Forouhar Graff speaks about the unique approach to prescribing Fellows learn – psychodynamic psychopharmacology – during their training at Riggs.

  •  neural mediators of psychotherapeutic change, and human development.

    Spring 2017 issue of Austen Riggs Center, ARC News, featuring articles on three strategic initiatives: clinical systems, neural mediators of psychotherapeutic change, and human development.

  • Austen Riggs Staff Psychiatrist Elizabeth Weinberg, MD, and Research Psychologist Katie Lewis, PhD, respond to a Scientific American article about suicide risk assessment.

    In their recently published Scientific American article “Suicide Risk Assessment Doesn’t Work,” Declan Murray and Patrick Devitt note the limitations of using risk factors in assessing suicide risk and address a significant problem in mental health. We agree with the conclusion that over-reliance on formulaic assessment can interfere with real engagement with patients. We cannot agree, however, that the best recommended practice is to send suicidal patients home with the reassurance that statistically they are likely to stay alive "no matter what we do."

  • The Austen Riggs Neural Mediators of Psychotherapeutic Change Strategic Initiative will use new neuroimaging hardware and software technologies to better understand both the brain and the mind in mental illness

    Austen Riggs Center Medical Director/CEO Andrew J. Gerber, MD, PhD, talks about the Neural Mediators of Psychotherapeutic Change strategic initiative taking form at Riggs. 

  • David Mintz, MD, Team Leader/Staff Psychiatrist at the Austen Riggs Center.

    Austen Riggs Center staff psychiatrist David Mintz, MD, talks about the Psychodynamic Psychopharmacology strategic initiative taking form at Riggs. 

  • Jane Tillman, PhD, ABPP

    Barbara Taylor, a noted historian and professor of humanities, has written a memoir of her long, and at times harrowing, psychoanalysis and psychiatric hospitalization. In The last asylum: A memoir of madness in our times, Taylor goes beyond a standard autobiographical account and links her personal history to the sociocultural history of the asylum movement of the past 150 years.

  • Eric M. Plakun, MD, DLFAPA, FACPsych, Associate Medical Director and Director of Admissions

    Austen Riggs Center Director of Biopsychosocial Advocacy Eric M. Plakun, MD, talks about the Biopsychosocial Advocacy strategic initiative at Riggs.

  • Andrew J. Gerber, MD, PhD, is the CEO/Medical Director of the Austen Riggs Center in Stockbridge, MA.

    Psychiatry has long utilized symptom clusters to classify mental illness, and today the Diagnostic and Statistical Manual of Mental Disorders (DSM), which outlines specific conditions as independent entities, remains the standard tool in the field. However, in the past decade or so, there has been growing interest in new ways to characterize mental illness, such as through gene mutations or physiological recordings, which have the potential of adding depth and dimensionality to the understanding of mental illness, and of informing the treatment trajectory.

  • Austen Riggs Center Medical Director/CEO Andrew J. Gerber, MD, PhD, explores neuroimaging research and advances that may expand our understanding psychotherapeutic change. 



Subscribe to RSS - Psychiatry